Fibromodulin promoted in vitro and in vivo angiogenesis

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 530-535

  Jian, Jia ^a   Zheng, Zhong ^a   Zhang, Kermit ^a   Rackohn, Todd Matthew ^a   Hsu, Chingyun ^a   Levin, Andrew ^a   Enjamuri, Dwarak Reddy ^a   Zhang, Xinli ^a   Ting, Kang ^a   Soo, Chia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Fibromodulin; Human endothelial HUVEC CS cell; In ovo chick embryo chorioallantoic membrane (CAM) assay; Tube like structure formation

Indexed keywords

ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBROMODULIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL VIABILITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING;

ANGIOGENESIS; FIBROMODULIN; HUMAN ENDOTHELIAL HUVEC-CS CELL; IN OVO CHICK EMBRYO CHORIOALLANTOIC MEMBRANE (CAM) ASSAY; TUBE-LIKE STRUCTURE FORMATION;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-2; ANIMALS; CELL ADHESION; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COLLAGEN TYPE III; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STRESS FIBERS; VINCULIN;

MUS; SPONDIAS PURPUREA;

EID: 84879883451     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.005     Document Type: Article

References (46)

1. Breier G. Angiogenesis in embryonic development--a review. Placenta 2000, 21(Suppl A):S11-S15.
2. Eming S.A., Brachvogel B., Odorisio T., Koch M. Regulation of angiogenesis: wound healing as a model. Prog. Histochem. Cytochem. 2007, 42:115-170.
3. Nussenbaum F., Herman I.M. Tumor angiogenesis: insights and innovations. J. Oncol. 2010, 2010:132641.
4. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., Cheresh D.A. Definition of 2 angiogenic pathways by distinct alpha(v) integrins. Science 1995, 270:1500-1502.
5. Belotti D., Foglieni C., Resovi A., Giavazzi R., Taraboletti G. Targeting angiogenesis with compounds from the extracellular matrix. Int. J. Biochem. Cell Biol. 2011, 43:1674-1685.
6. Britsch S., Christ B., Jacob H.J. The influence of cell-matrix interactions on the development of quail chorioallantoic vascular system. Anat. Embryol. (Berl.) 1989, 180:479-484.
7. Davis G.E., Camarillo C.W. An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 1996, 224:39-51.
8. Stromblad S., Cheresh D.A. Cell adhesion and angiogenesis. Trends Cell Biol. 1996, 6:462-468.
9. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim. Biophys. Acta, Rev. Cancer 2004, 1654:13-22.
10. Krishnan L., Hoying J.B., Nguyen H., Song H., Weiss J.A. Interaction of angiogenic microvessels with the extracellular matrix. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3650-H3658.
11. Whelan M.C., Senger D.R. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem. 2003, 278:327-334.
12. Iozzo R.V., Goldoni S., Berendsen A.D., Young M.F. Small Leucine-Rich Proteoglycans: The Extracellular Matrix: an Overview 2011, 197-231. Springer, Berlin Heidelberg. R.P. Mecham (Ed.).
13. Heinegard D., Antonsson P., Hedbom E., Larsson T., Oldberg A., Sommarin Y., Wendel M. Noncollagenous matrix constituents of cartilage. Pathol. Immunopathol. Res. 1988, 7:27-31.
14. Bi Y., Ehirchiou D., Kilts T.M., Inkson C.A., Embree M.C., Sonoyama W., Li L., Leet A.I., Seo B.M., Zhang L., Shi S., Young M.F. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 2007, 13:1219-1227.
15. Zheng Z., Jian J., Zhang X.L., Zara J.N., Yin W., Chiang M., Liu Y., Wang J., Pang S., Ting K., Soo C. Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin. Biomaterials 2012, 33:5821-5831.
16. Soo C., Hu F., Zhang X., Wang Y., Beanes S., Lorenz H., Hedrick M., Mackool R., Plaas A., Kim S., Longaker M.T., Freymiller E., Ting K. Differential expression of fibromodulin, a transforming growth factor-β modulator, in fetal skin development and scarless repair. Am. J. Pathol. 2000, 157:423-433.
17. Soo C., Beanes S., Dang C., Zhang X., Ting K. Fibromodulin, a TGF-β modulator, promotes scarless fetal repair. Surg. Forum 2001, 578-581.
18. Stoff A., Rivera A.A., Mathis J.M., Moore S.T., Banerjee N.S., Everts M., Espinosa-de-los-Monteros A., Novak Z., Vasconez L.O., Broker T.R., Richter D.F., Feldman D., Siegal G.P., Stoff-Khalili M.A., Curiel D.T. Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J. Mol. Med. 2007, 85:481-496.
19. Zheng Z., Nguyen C., Zhang X.L., Khorasani H., Wang J.Z., Zara J.N., Chu F., Yin W., Pang S., Le A., Ting K., Soo C. Delayed wound closure in fibromodulin-deficient mice is associated with increased TGF-beta 3 signaling. J. Invest. Dermatol. 2011, 131:769-778.
20. Carpentier G. Contribution: angiogenesis analyzer for ImageJ. ImageJ News 2012, http://rsb.info.nih.gov/ij/notes.html.
21. Osako M.K., Nakagami H., Koibuchi N., Shimizu H., Nakagami F., Koriyama H., Shimamura M., Miyake T., Rakugi H., Morishita R. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ. Res. 2010, 107:466-475.
22. Davies C.d.L., Melder R.J., Munn L.L., Mouta-Carreira C., Jain R.K., Boucher Y. Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. Microvasc. Res. 2001, 62:26-42.
23. Dooley T.P., Reddy S.P., Wilborn T.W., Davis R.L. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR. Biochem. Biophys. Res. Commun. 2003, 306:1026-1036.
24. Thijssen V.L.J.L., Brandwijk R.J.M.G.E., Dings R.P.M., Griffioen A.W. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp. Cell Res. 2004, 299:286-293.
25. West D.C., Thompson W.D., Sells P.G., Burbridge M.F. Angiogenesis Assays Using Chick Chorioallantoic Membrane. Angiogenesis Protocols 2011, 46:107-129. Humana Press Inc., Totowa, NJ. J.C. Murray (Ed.).
26. Iruela-Arispe M.L., Hasselaar P., Sage H. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 1991, 64:174-186.
27. Aranda E., Owen G.I. A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol. Res. 2009, 42:377-389.
28. Fagiani E., Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013, 328:18-26.
29. Niewiarowska J., Brezillon S., Sacewicz-Hofman I., Bednarek R., Maquart F.X., Malinowski M., Wiktorska M., Wegrowski Y., Cierniewski C.S. Lumican inhibits angiogenesis by interfering with alpha2beta1 receptor activity and downregulating MMP-14 expression. Thromb. Res. 2011, 128:452-457.
30. Schonherr E., Sunderkotter C., Schaefer L., Thanos S., Grassel S., Oldberg A., Iozzo R.V., Young M.F., Kresse H. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J. Vasc. Res. 2004, 41:499-508.
31. Neill T., Painter H., Buraschi S., Owens R.T., Lisanti M.P., Schaefer L., Iozzo R.V. Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J. Biol. Chem. 2012, 287:5492-5506.
32. Jarvelainen H., Puolakkainen P., Pakkanen S., Brown E.L., Hook M., Iozzo R.V., Sage E.H., Wight T.N. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen. 2006, 14:443-452.
33. Sulochana K.N., Fan H.P., Jois S., Subramanian V., Sun F., Kini R.M., Ge R.W. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J. Biol. Chem. 2005, 280:27935-27948.
34. Mimura T., Han K.Y., Onguchi T., Chang J.H., Kim T.I., Kojima T., Zhou Z.J., Azar D.T. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. J. Vasc. Res. 2009, 46:541-550.
35. Salomaki H.H., Sainio A.O., Soderstrom M., Pakkanen S., Laine J., Jarvelainen H.T. Differential expression of decorin by human malignant and benign vascular tumors. J. Histochem. Cytochem. 2008, 56:639-646.
36. Theocharis A.D., Skandalis S.S., Tzanakakis G.N., Karamanos N.K. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J. 2010, 277:3904-3923.
37. Ingber D.E., Folkman J. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro - role of extracellular-matrix. J. Cell Biol. 1989, 109:317-330.
38. Merline R., Schaefer R.M., Schaefer L. The matricellular functions of small leucine-rich proteoglycans. J. Cell Commun. Signal. 2009, 3:323-335.
39. Oldberg A., Kalamajski S., Salnikov A.V., Stuhr L., Morgelin M., Reed R.K., Heldin N.E., Rubin K. Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc. Natl. Acad. Sci. USA 2007, 104:13966-13971.
40. Iozzo R.V., Schaefer L. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J. 2010, 277:3864-3875.
41. Zheng Z., Nguyen K., Wang J.Z., Zhang X., Ting K., Soo C. Differential expression of transforming growth factor (TGF)-betas and TGF-beta receptors during skin wound healing in adult mice with fibromodulin (FMOD) deficiency. Wound Repair Regen. 2008, 16. A28-A28.
42. Folkman J. P.A. DAmore, Blood vessel formation: what is its molecular basis?. Cell 1996, 87:1153-1155.
43. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997, 277:48-50.
44. Mayr C., Bund D., Schlee M., Moosmann A., Kofler D.M., Hallek M., Wendtner C.M. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8(+) autologous T lymphocytes. Blood 2005, 105:1566-1573.
45. Mikaelsson E., Danesh-Manesh A.H., Luppert A., Jeddi-Tehrani M., Rezvany M.R., Sharifian R.A., Safaie R., Roohi A., Osterborg A., Shokri F., Mellstedt H., Rabbani H. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Blood 2005, 105:4828-4835.
46. Iozzo R.V., Sanderson R.D. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell Mol. Med. 2011, 15:1013-1031.